Skip to main content
. Author manuscript; available in PMC: 2016 Sep 15.
Published in final edited form as: Clin Cancer Res. 2015 May 12;21(18):4048–4054. doi: 10.1158/1078-0432.CCR-15-0215

Table 4.

Multivariable Model – Factors Associated with Occurrence of Event (Any Criteria)

Parameter Levels OR 95% CI Wald p
Arm Sunitinib vs. Placebo 1.23 0.89 – 1.69 0.21
Sorafenib vs. Placebo 1.05 0.76 – 1.46 0.76
Sex Male vs. Female 1.40 1.04 – 1.88 0.03
Treatment Duration (months) 1.04 1.01 – 1.08 0.024
Baseline LVEF 1.10 1.08 – 1.12 <0.0001